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Submicroscopic chromosomal anomalies play an important role in the etiology of craniofacial malfor-
mations, including midline facial defects with hypertelorism (MFDH). MFDH is a common feature
combination in several conditions, of which Frontonasal Dysplasia is the most frequently encountered
manifestation; in most cases the etiology remains unknown. We identiﬁed a parent to child transmission
of a 6.2 Mb interstitial deletion of chromosome region 2q36.1q36.3 by array-CGH and conﬁrmed by FISH
and microsatellite analysis. The patient and her mother both presented an MFDH phenotype although
the phenotype in the mother was much milder than her daughter. Inspection of haplotype segregation
within the family of 2q36.1 region suggests that the deletion arose on a chromosome derived from the
maternal grandfather. Evidences based on FISH, microsatellite and array-CGH analysis point to a high
frequency mosaicism for presence of a deleted region 2q36 occurring in blood of the mother. The
frequency of mosaicism in other tissues could not be determined. We here suggest that the milder
phenotype observed in the proband’s mother can be explained by the mosaic state of the deletion. This
most likely arose by an early embryonic deletion in the maternal embryo resulting in both gonadal and
somatic mosaicism of two cell lines, with and without the deleted chromosome. The occurrence of
gonadal mosaicism increases the recurrence risk signiﬁcantly and is often either underestimated or not
even taken into account in genetic counseling where new mutation is suspected.
 2012 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Methods of detection
1.1. Cytogenetics
Conventional cytogenetic analysis of GTG-banded chromosomes
from cultured lymphocytes of the proband and her mother per-
formed at a resolution of 300e400 bands (low resolution) showed
an apparently normal (46,XX) karyotype in both mother and
daughter.1.2. Array-CGH
Genomic DNA was extracted from the peripheral blood of both
family members according to standard protocols. Array-CGH.
a-Silva-Lopes).
nder the Elsevier OA license.investigation of the proband was carried out using the 30K
Whole Genome Tile Path (WGTP) BAC array from the Sanger Center
(Wellcome Trust, UK) as described by Fiegler et al. [1]. All copy-
number changes observed were compared to copy-number vari-
ants (CNVs) reported in previous studies at normal populations as
documented in the Database of Genomic Variants (DGV; http://
projects.tcag.ca/variation/). Chromosome regions not previously
reported as CNVs and comprising at least two consecutive clones
were singled out for further investigate by conﬁrmatory studies,
FISH analysis and microsatellite markers. Subsequently, further
high resolution CGH using a 180K Agilent platform was performed
in Sao Paulo on both family members.
1.3. Chromosomal anomaly
Array-CGH analysis of the proband showed an interstitial dele-
tion of 6.2 Mb at 2q36.1q36.3 (NCBI Build 36, Feb 2007). The
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266H19 e last clone not deleted) and 222,317,564 bp (RP11-92G23
ﬁrst deleted clone); while the distal breakpoint was located
between 228,717,289 bp (RP11-422G1) and 228,536,996 bp (RP11-
122A7) (respectively, the last deleted probe and the ﬁrst non-
deleted probe). The deleted region contained 40 probes.
FISH analysis was carried out to conﬁrm the alteration revealed
in the proband.
1.4. Methods of conﬁrmation
FISH was performed on metaphase slides from peripheral blood
lymphocytes using standard techniques. Two BAC clones [RP11-
71J24 (2q36.1) and RP11-211K17 (2q36.3)] mapping within the
deleted region (Ensembl Genome Browser e NCBI build 36) were
chosen. BAC DNAs were extracted usingWizard Plus SVMinipreps
DNA Puriﬁcation System (Promega Corporation, Madison) and
differentially labeled by Nick Translation (Roche Applied Science,Fig. 1. Pedigree of the family and haplotype analysis performed in family members using the
an apparently very sensitive microsatellite allele for a locus located in the center of the de
a single allele if the deletion was non-mosaic.Indianapolis, IN) with ﬂuorescein-12-dUTP and tetramethil-
rhodamine-6-dUTP. The deletion was conﬁrmed in 20 metaphase
cells analyzed from the proband. FISH was also performed on 50
metaphases from the mother and, although a single signal as ex-
pected in the presence of the deletion was observed in 90% of the
cells analyzed (45 cells), ﬁve cells were observed with two signals
suggesting a 10% mosaicism in this limited sample. Further
conﬁrmation for the presence of mosaicism was derived from
microsatellite haplotype analysis: an apparently very sensitive
microsatellite allele for a locus in the center of the deletion gave
a heterozygote signal in the mother when it should have been
a single allele if the deletion was non-mosaic; construction of the
haplotypes of the region in the entire pedigree using 5 micro-
satellite loci demonstrated that the deletion must have arisen on
the 2q36 region derived from the maternal grandfather and that
this particular allele could only have come from him (Fig. 1). Lastly,
recently performed high resolution CGH using a 180K Agilent
platform demonstrated a small yet detectable difference in themicrosatellite markers D2S126, D2S2197, D2S2354, D2S2308 and D2S396 at 2q36. Note
letion (D2S2354) gave a heterozygote signal in the mother when it should have been
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was hybridized against that of the daughter, suggesting an
approximately 15% mosaicism in blood of the mother (Fig. 2).
1.5. Cause of the abnormal phenotype?
The deletionwas considered as the cause of the phenotype since
it is larger than 6 Mb, deleted site/region harbors more than 20
genes although EPHA4, COL4A3, COL4A4 and PAX3 of them can be
considered responsible from the phenotype due to their effect at
heterozygote state, by haploinsufﬁciency.
2. Clinical description
Theprobandwasborn fromanAfricaneBrazilian fatherof27years
and LatinoeBrazilian mother aged 23, and had two healthy sisters.
The newborn had a weight of 1840 g (<3rd centile) and length ofFig. 2. Array-CGH proﬁle of chromosome 2q36 showing the deleted area. (A) Demonstration
DNA of the mother was hybridized against that of the daughter, suggesting an approximatel
against a control DNA showing the deletion (orange) on the up side; DNA from the mother
ratio of probes within the deletion at the proband is higher (media ¼ 0, 71) than the log2-45 cm (<3rd centile) at 38 gestationalweeks. Hypotoniawas the only
major health concern at birth. She exhibited delayed developmental
milestones, bywalkingatonlyat2.5 years and speaking just twoword
sentences at 3 years. Physical examination at 11 years and 9 months
(Fig. 3) revealed a height of 152 cm (50e75th centile), a weight of
37.4 kg (25e50th centile) and head circumference of 51.5 cm
(50e10th centile). She had dolichocephaly, a broad forehead with bi-
temporal narrowing, low posterior hairline, hypertelorism and tele-
canthus (outer canthal distance 10.7 cm, >97th centile and inner
canthal distance 5.2 cm, >97th centile), mild synophrys, nose with
awide and biﬁd base, malar ﬂattening, overcrowded teeth within an
alveolar ridge and high narrow palate, hypertrichosis and skeletal
ﬁndings consisting of pectus excavatum, severe thoracolumbar
scoliosis, tapering ﬁngers and bilateral 5th ﬁnger clinodactyly. She
hadnormalpubertaldevelopmentB2P3,withnormaldevelopmentof
axillaryhair, butwithhypoplasic outer vaginal lips. Ophthalmological
examination and abdominal ultrasound results were normal.of a small yet detectable difference in the log2-ratio of probes within the deletion when
y 15% mosaicism in blood of the mother. (B) DNA from the proband (green) hybridized
(red) hybridized against a control DNA showing the deletion (blue). Note that the log2-
ratio of probes within the deletion at the mother (media ¼ 0, 69).
Fig. 3. Clinical features of the patient at the age of 11 years and 9 months. Frontal view
showing a broad forehead, ocular hypertelorism and telecanthus, short philtrum and
wide base of the nose with bulbous biﬁd tip.
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motor coordination and hypotonia.MRI ﬁndings showed frontal lobe
anteriorization and enlarged talamic commissure.
The mother (Fig. 4), was mentally normal, had mild hyper-
telorism with outer canthal distance 11.3 cm (>97th centile) and
inner canthal distance 4.2 cm (>97th centile), short stature (height
146 cm, <3rd centile) and left congenital hip dislocation. Maternal
grandmother and maternal aunt also showed hypertelorism
although they were not formally physically examined.
3. Discussion
Midline Facial Defects with Ocular Hypertelorism (MFDH) are
common features in several conditions. The most frequentlyFig. 4. Front view of the mother showing the ocular hypertelorism, nose with wide
base and broad tip, short philtrum, overcrowded teeth.clinically recognized anomaly is Frontonasal Dysplasia (FND; OMIM
136760). MFDH is characterized by ocular hypertelorism, biﬁd nose,
cranium biﬁdum, widow’s peak, median cleft lip and (or) lateral
cleft lip and cleft palate; structural and functional anomalies of the
central nervous system are also often described. They can occur
isolated or as part of a syndrome. In most cases the etiology is
unknown, possibly because of the relative rarity of MFDH [2].
Cytogenetic imbalances involving different chromosomes [3] and
mutations in developmental genes, such as ALX1, ALX3 [4] and ALX4
[5] have been reported in association with craniofrontonasal
dysplasias.
We describe occurrence of a mother and a daughter presenting
the MFDH phenotype associated with a 2q36.1q36.3 deletion. The
phenotype of the mother is signiﬁcantly milder than that presented
by her daughter; this is probably due to the occurrence of the
deletion in mosaic form in the mother. Mosaicism comprising
a normal cell line and a cell line harboring an unbalanced auto-
somal structural rearrangement different from a ring or marker
chromosome is rare. Nevertheless, cases of mosaicism for pure
interstitial deletions or duplications, resulting in parent-to-child
transmission, have been previously described. Clinical presenta-
tion is known to vary according to somatic mosaicism frequency
and tissue distribution [9]. Since only lymphocytes were analyzed
here, the tissue distribution and frequency of mosaicism in tissues
other than blood remains unknown. The milder phenotype of the
mother is probably due to the admixture of deletion and normal
cell lines [9]. There are many examples in the literature where
mosaicism has arisen at an early embryonic stage in the mother;
this either occurs directly in the ovary as a lineage of oogonia, or if
prior to gonadal formation, it occurs at an even earlier embryonic
stage and both somatic and gonadal lines become established in
a mosaic form. It is a reasonable supposition that, as in the mother
of the proband described here, the presence of both gonadal and
somatic mosaicism indicates the mutation occurred prior to ovary
formation. For several disorders including Duchenne and Becker
muscular dystrophies, osteogenesis imperfect type II and tuberous
sclerosis, in what are apparently new mutation situations a signif-
icant increase in recurrence risk occurs due to gonadal mosaicism.
The best documented evidence emanates from DMD where,
because of both the high mutation rate and disease frequency, it is
relative easy to calculate that the average recurrence risk is w7%.
This value approximately corresponds also to the frequency of
gonadal mosaicism in DMD in ostensibly new mutation situations
[10]. The direct relevance of the DMD situation to the interstitial
deletion described here is that more than 65% of all DMDmutations
are also large interstitial deletions. However, we must assume that
unlike DMD, such de novo deletions are normally extremely rare,
but when they do so they may also occur as mosaics.
The 6.2 Mb deletion at 2q36 presented by the proband and her
mother comprises at least 20 annotated genes.We have listed those
genes that appear to be the most relevant to contributing to the
phenotype based on their known effect of point mutations or
chromosome rearrangements as presented in the OMIM Gene Map
and Morbid Map (Table 1). We also discuss the role of some genes
located in the deleted region that were previously related to other
clinical phenotypes or mouse mutations.
The phenotype presented by the proband has similarities to the
CranioFrontoNasal syndrome (CFNS) normally caused by EFNB1
mutations [6]. Ephrin (EFN) and the Eph receptor (EPH) gene family
are widely expressed in the developing brain [7]. The EPHA4 gene is
involved in cell proliferation during cerebral cortical development
[8] and we believe that the patient’s phenotype is partially caused
by deletion of this gene.
COL4A3 and COL4A4 mutations, both type IV collagens, cause
two syndromes: Alport and Goodpasture. Both of these syndromes
Table 1
List of OMIM genes located in the 2q36 deleted region and associated diseases (according to OMIM Gene Map).
Gene/locus Gene/locus name Gene/Locus
MIM number
Phenotype Phenotype MIM number
EPHA4 EPH receptor A4 602188
PAX3 Paired box 3 606597 Craniofacial-deafness-
hand syndrome
122880
Rhabdomyosarcoma
2, alveolar
268220
Waardenburg
syndrome, type 1
193500
Waardenburg
syndrome, type 3
148820
SGPP2 Sphingosine-
1-phosphate
phosphatase 2
612827
FARSLB Phenylalanine-tRNA
synthetase-like,
beta subunit
609690
ACSL3 Acyl-CoA synthetase
long-chain family
member 3
602371
KCNE4 Potassium channel,
voltage-gated, Isk-related
family, member 4
607775
SCG2 Secretogranin II 118930
MRPL44 Mitochondrial ribosomal
protein L44
611849
SERPINE2 Protease inhibitor 7
(protease nexin I)
177010
e e e Rajab syndrome 613658
CUL3 Cullin 3 603136 Pseudohypoaldosteronism,
type IIE
614496
DOCK10 Dedicator of cytokinesis 10 611518
IRS1 Insulin receptor substrate 1 147545 {Coronary artery disease,
susceptibility to}
{Diabetes mellitus,
noninsulin-dependent}
125853
COL4A4 Collagen IV, alpha-4
polypeptide
120131 Alport syndrome,
autosomal recessive
203780
Hematuria, familial
benign
COL4A3 Collagen IV, alpha-3
polypeptide (Goodpasture
antigen)
120070 Alport syndrome,
autosomal recessive
203780
Hematuria, benign familial 141200
AGFG1 ArfGAP with FG repeats 1 600862
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cient to cause these diseases. However, we hypothesize that hap-
loinsufﬁency of the COL4A3 and COL4A4 genes may explain the
skeletal/joint complications observed in the proband.
The deleted region also includes the PAX3 gene, a candidate
gene for development of the MFDH phenotype. PAX3 has a crucial
role in embryonic development, acting on structures derived from
the neural crest and skeletal muscle [11e13]. Alterations in PAX3 are
frequently found in the Waardenburg syndrome, which often
exhibits ocular hypertelorism and deafness. Although the family
reported here was not investigated speciﬁcally for deafness, there
were no recorded complaints from family member interviews.
Abnormalities of the skull, ribs and vertebrae, and fusion of bones
in the shoulder and hip regions have also been noted in Pax3Sp/Sp
(Splotch) null mouse embryos [14].
Another interstitial 2q36 deletion case previously described in
the literature by Doco-Fenzy and colleagues [15] present some of
the clinical features observed in our patient, including low birth
weight, facial dysmorphism, global psychomotor developmental
delay and disorders of connective tissue. In the Doco-Fenzy case,
the deleted regionwas smaller (approximately 5.4 Mb) and located
more distally on chromosome 2 long arm. Importantly, the EPHA4
and PAX3 genes were not deleted and the patient had nohypertelorism; additionally, she had an enlarged kidney and
multiple renal cysts.
The prominant telecanthus and hypertelorism observed in the
proband can be best explained by haploinsufﬁency of the genes,
PAX3 and EPHA4. However, additional patients are needed to deﬁne
more precisely the phenotypic consequences of deletions in this
region.
In the context of this family, molecular cytogenetic testing,
including high resolution CGH, FISH and microsatellite analysis,
was valuable for genetic counseling purposes, since it demon-
strated the mother to be a somatic/gonadal mosaic carrier, where
the recurrence risk for a similarly affected child would have been
much higher than the practically zero value normally expected
with presumptive new mutations.
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